Hyperhemolysis in a sickle cell disease patient in pregnancy
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06264-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Kristen Warncke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA. kristen.warncke@utsouthwestern.edu. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hemolysis, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Sickle cell disease (SCD) is the most commonly inherited hemoglobinopathy with the potential for significant maternal and perinatal morbidity and mortality. Hyperhemolysis syndrome (HS) is a rare, and potentially fatal complication of blood transfusion characterized by destruction of both transfused and autologous red blood cells, often resulting in severe anemia with post-transfusion hemoglobin levels lower than pre-transfusion levels. Evidence-based guidance on the prevention and management of HS during pregnancy is limited. We report the case of a 23-year-old gravida 1 para 0 with sickle cell anemia and a history of two prior episodes of HS, successfully managed through a multidisciplinary approach. Her care team included hematologists, maternal-fetal medicine specialists, transfusion medicine pathologists, and neonatologists. Management during pregnancy involved initiating hydroxyurea in the second trimester, implementing a transfusion-restricted protocol, and utilizing immunosuppression and blood conservation strategies. This case highlights the successful application of a multidisciplinary approach to the management of a high-risk pregnancy complicated by SCD and recurrent HS. Key interventions included the use of hydroxyurea, erythropoiesis-stimulating agents, immunosuppression, and a planned delivery strategy, resulting in a favorable maternal and neonatal outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA. kristen.warncke@utsouthwestern.edu.
- Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9032, USA. kristen.warncke@utsouthwestern.edu.
- Department of Hematology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zitieren
APA
Warncke, K., Nero, A., Sarode, R., Adkins, B. D., Morgan, J., & Bavli, N. (2025). Hyperhemolysis in a sickle cell disease patient in pregnancy. Annals of Hematology. https://doi.org/10.1007/s00277-025-06264-7
Vancouver
Warncke K, Nero A, Sarode R, Adkins BD, Morgan J, Bavli N. Hyperhemolysis in a sickle cell disease patient in pregnancy. Annals of Hematology. 2025. doi:10.1007/s00277-025-06264-7
BibTeX
@article{Warncke2025,
author = {Warncke, Kristen and Nero, Alecia and Sarode, Ravindra and Adkins, Brian D and Morgan, Jamie and Bavli, Natalie},
title = {Hyperhemolysis in a sickle cell disease patient in pregnancy},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06264-7}
}
EUVIMED